Biotinylated Human SOST / Sclerostin Protein, His Tag, ultra sensitivity (primary amine labeling)

Catalog Number: ABS-SOT-H8245-25UG
Article Name: Biotinylated Human SOST / Sclerostin Protein, His Tag, ultra sensitivity (primary amine labeling)
Biozol Catalog Number: ABS-SOT-H8245-25UG
Supplier Catalog Number: SOT-H8245-25ug
Alternative Catalog Number: ABS-SOT-H8245-25UG
Manufacturer: AcroBiosystems
Host: Human
Category: Proteine/Peptide
Species Reactivity: Human
Conjugation: Biotin
Sclerostin (SOST) is also known as Sclerosteosis, VBCH, is a secreted glycoprotein with a signal peptide for secretion and a Cterminal cysteine knotlike (CTCK) domain and belongs to the Cerberus/DAN family of bone morphogenetic protein (BMP) antagonists. Sclerostin is produced by the osteocyte and has antianabolic effects on bone formation. More recently Sclerostin has been identified as binding to LRP5/6 receptors and inhibiting the Wnt signalling pathway. Wnt pathway inhibition under these circumstances is antagonistic to bone formation (meaning Sclerostin antagonizes bone formation). It has been shown that SOST binds BMP5, 6, and 7 with high affinity and BMP2 and 4 with low affinity. Sclerostin production by osteocytes is inhibited by parathyroid hormone, mechanical loading and cytokines including oncostatin M, cardiotrophin1 and leukemia inhibitory factor. Sclerostin production is increased by calcitonin. Thus, osteoblast activity is self regulated by a negative feedback system. Mutations of Sclerostin is associated with the syndrome Sclerosteosis, and reduced sclerostin expression results in a milder form of the disorder called van Buchem disease. - Proteine/Peptide
Molecular Weight: 22.3 kDa
Tag: N-6*His
NCBI: 01087
Buffer: PBS, pH7.4
Expression System: Gln 24 - Tyr 213
Purity: 95%
Form: Powder
Target: SOST
SOT-H8245-25ug